Meloxicam is an enol nonsteroidal anti-inflammatory drug with anti-inflammatory, analgesic and antipyretic effects.Selective inhibition of cox-2 (cox-2), the inhibition of cox-1 is weak, so the digestive system and other adverse reactions are less.

The global Meloxicam market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for Meloxicam is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Meloxicam is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Meloxicam include Boehringer Ingelheim, Baudax, Perrigo, Recro Pharma, Iroko Pharma, Zyla Life Sciences, Axsome Therapeutics, Orbis Biosciences and Cellix Bio, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Meloxicam, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Meloxicam.

Report Scope

The Meloxicam market size, estimations, and forecasts are provided in terms of sales volume (KG) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Meloxicam market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Meloxicam manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Meloxicam Market Report

Report Metric	Details
Report Name	Meloxicam Market
Segment by Type	by Ingredient Combination Drugs Prescribed Drugs by Route Oral Intravenou by Dosage Form Tablets Capsule Granules Other
Segment by Application	Rheumatoid Arthritis Osteoarthritis Soft Tissue Inflammation Traumatic Pain Post-Operative Pain Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Boehringer Ingelheim, Baudax, Perrigo, Recro Pharma, Iroko Pharma, Zyla Life Sciences, Axsome Therapeutics, Orbis Biosciences, Cellix Bio, Ligand Pharma, SEDOR Pharma, Heron Therapeutics, Pacira BioSciences, Sanofi, Eurofarma Laboratorio, TerSera Therapeutics, Apotex, Yung Shin Pharmaceutical, Breckenridge Pharmaceutical, Zydus Pharmaceuticals, Unichem Pharmaceuticals, Strides Pharma, Cipla, Dr. Reddy's Laboratories, Glenmark Pharmaceuticals, Teva, PuraCap Pharmaceutical, TARO, Lupin Pharmaceuticals, Aurobindo Pharma, Shanghai Bolinger Ingelheim Pharmaceutical, Shanghai Zhaohui Pharmaceutical, Sichuan Shenghe Pharmaceutical, Ningxia Kangya Pharmaceutical, Yangtze Pharmaceutical Group, Kunshan Longdeng Ruidi Pharmaceutical, Jiangsu Yabang Epson Pharmaceutical, Jiangsu Feima Pharmaceutical Co. , Ltd, Zhejiang Xianju Pharmaceutical, Hainan All Star Pharmaceutical, Hainan Aomeihua Pharmaceutical, Hunan Mingrui Pharmaceutical, Suzhou Sinochem Pharmaceutical, Qilu Pharmaceutical, Sichuan Luye Pharmaceutical, Shandong Xinhua Pharmaceutical, Guangdong Renkang Pharmaceutical, Hainan Selike Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Meloxicam manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Meloxicam in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Meloxicam Market report?

Ans: The main players in the Meloxicam Market are Boehringer Ingelheim, Baudax, Perrigo, Recro Pharma, Iroko Pharma, Zyla Life Sciences, Axsome Therapeutics, Orbis Biosciences, Cellix Bio, Ligand Pharma, SEDOR Pharma, Heron Therapeutics, Pacira BioSciences, Sanofi, Eurofarma Laboratorio, TerSera Therapeutics, Apotex, Yung Shin Pharmaceutical, Breckenridge Pharmaceutical, Zydus Pharmaceuticals, Unichem Pharmaceuticals, Strides Pharma, Cipla, Dr. Reddy's Laboratories, Glenmark Pharmaceuticals, Teva, PuraCap Pharmaceutical, TARO, Lupin Pharmaceuticals, Aurobindo Pharma, Shanghai Bolinger Ingelheim Pharmaceutical, Shanghai Zhaohui Pharmaceutical, Sichuan Shenghe Pharmaceutical, Ningxia Kangya Pharmaceutical, Yangtze Pharmaceutical Group, Kunshan Longdeng Ruidi Pharmaceutical, Jiangsu Yabang Epson Pharmaceutical, Jiangsu Feima Pharmaceutical Co. , Ltd, Zhejiang Xianju Pharmaceutical, Hainan All Star Pharmaceutical, Hainan Aomeihua Pharmaceutical, Hunan Mingrui Pharmaceutical, Suzhou Sinochem Pharmaceutical, Qilu Pharmaceutical, Sichuan Luye Pharmaceutical, Shandong Xinhua Pharmaceutical, Guangdong Renkang Pharmaceutical, Hainan Selike Pharmaceutical

What are the Application segmentation covered in the Meloxicam Market report?

Ans: The Applications covered in the Meloxicam Market report are Rheumatoid Arthritis, Osteoarthritis, Soft Tissue Inflammation, Traumatic Pain, Post-Operative Pain, Other

What are the Type segmentation covered in the Meloxicam Market report?

Ans: The Types covered in the Meloxicam Market report are by Ingredient, Combination Drugs, Prescribed Drugs, by Route, Oral, Intravenou, by Dosage Form, Tablets, Capsule, Granules, Other

1 Meloxicam Market Overview

1.1 Product Overview and Scope of Meloxicam

1.2 Meloxicam Segment by Ingredient

1.2.1 Global Meloxicam Market Value Comparison by Ingredient (2024-2030)

1.2.2 Combination Drugs

1.2.3 Prescribed Drugs

1.3 Meloxicam Segment by Application

1.3.1 Global Meloxicam Market Value by Application: (2024-2030)

1.3.2 Rheumatoid Arthritis

1.3.3 Osteoarthritis

1.3.4 Soft Tissue Inflammation

1.3.5 Traumatic Pain

1.3.6 Post-Operative Pain

1.3.7 Other

1.4 Global Meloxicam Market Size Estimates and Forecasts

1.4.1 Global Meloxicam Revenue 2019-2030

1.4.2 Global Meloxicam Sales 2019-2030

1.4.3 Global Meloxicam Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Meloxicam Market Competition by Manufacturers

2.1 Global Meloxicam Sales Market Share by Manufacturers (2019-2024)

2.2 Global Meloxicam Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Meloxicam Average Price by Manufacturers (2019-2024)

2.4 Global Meloxicam Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Meloxicam, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Meloxicam, Product Type & Application

2.7 Meloxicam Market Competitive Situation and Trends

2.7.1 Meloxicam Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Meloxicam Players Market Share by Revenue

2.7.3 Global Meloxicam Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Meloxicam Retrospective Market Scenario by Region

3.1 Global Meloxicam Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Meloxicam Global Meloxicam Sales by Region: 2019-2030

3.2.1 Global Meloxicam Sales by Region: 2019-2024

3.2.2 Global Meloxicam Sales by Region: 2025-2030

3.3 Global Meloxicam Global Meloxicam Revenue by Region: 2019-2030

3.3.1 Global Meloxicam Revenue by Region: 2019-2024

3.3.2 Global Meloxicam Revenue by Region: 2025-2030

3.4 North America Meloxicam Market Facts & Figures by Country

3.4.1 North America Meloxicam Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Meloxicam Sales by Country (2019-2030)

3.4.3 North America Meloxicam Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Meloxicam Market Facts & Figures by Country

3.5.1 Europe Meloxicam Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Meloxicam Sales by Country (2019-2030)

3.5.3 Europe Meloxicam Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Meloxicam Market Facts & Figures by Country

3.6.1 Asia Pacific Meloxicam Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Meloxicam Sales by Country (2019-2030)

3.6.3 Asia Pacific Meloxicam Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Meloxicam Market Facts & Figures by Country

3.7.1 Latin America Meloxicam Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Meloxicam Sales by Country (2019-2030)

3.7.3 Latin America Meloxicam Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Meloxicam Market Facts & Figures by Country

3.8.1 Middle East and Africa Meloxicam Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Meloxicam Sales by Country (2019-2030)

3.8.3 Middle East and Africa Meloxicam Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Meloxicam Sales by Type (2019-2030)

4.1.1 Global Meloxicam Sales by Type (2019-2024)

4.1.2 Global Meloxicam Sales by Type (2025-2030)

4.1.3 Global Meloxicam Sales Market Share by Type (2019-2030)

4.2 Global Meloxicam Revenue by Type (2019-2030)

4.2.1 Global Meloxicam Revenue by Type (2019-2024)

4.2.2 Global Meloxicam Revenue by Type (2025-2030)

4.2.3 Global Meloxicam Revenue Market Share by Type (2019-2030)

4.3 Global Meloxicam Price by Type (2019-2030)

5 Segment by Application

5.1 Global Meloxicam Sales by Application (2019-2030)

5.1.1 Global Meloxicam Sales by Application (2019-2024)

5.1.2 Global Meloxicam Sales by Application (2025-2030)

5.1.3 Global Meloxicam Sales Market Share by Application (2019-2030)

5.2 Global Meloxicam Revenue by Application (2019-2030)

5.2.1 Global Meloxicam Revenue by Application (2019-2024)

5.2.2 Global Meloxicam Revenue by Application (2025-2030)

5.2.3 Global Meloxicam Revenue Market Share by Application (2019-2030)

5.3 Global Meloxicam Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Boehringer Ingelheim

6.1.1 Boehringer Ingelheim Corporation Information

6.1.2 Boehringer Ingelheim Description and Business Overview

6.1.3 Boehringer Ingelheim Meloxicam Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Boehringer Ingelheim Meloxicam Product Portfolio

6.1.5 Boehringer Ingelheim Recent Developments/Updates

6.2 Baudax

6.2.1 Baudax Corporation Information

6.2.2 Baudax Description and Business Overview

6.2.3 Baudax Meloxicam Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Baudax Meloxicam Product Portfolio

6.2.5 Baudax Recent Developments/Updates

6.3 Perrigo

6.3.1 Perrigo Corporation Information

6.3.2 Perrigo Description and Business Overview

6.3.3 Perrigo Meloxicam Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Perrigo Meloxicam Product Portfolio

6.3.5 Perrigo Recent Developments/Updates

6.4 Recro Pharma

6.4.1 Recro Pharma Corporation Information

6.4.2 Recro Pharma Description and Business Overview

6.4.3 Recro Pharma Meloxicam Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Recro Pharma Meloxicam Product Portfolio

6.4.5 Recro Pharma Recent Developments/Updates

6.5 Iroko Pharma

6.5.1 Iroko Pharma Corporation Information

6.5.2 Iroko Pharma Description and Business Overview

6.5.3 Iroko Pharma Meloxicam Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Iroko Pharma Meloxicam Product Portfolio

6.5.5 Iroko Pharma Recent Developments/Updates

6.6 Zyla Life Sciences

6.6.1 Zyla Life Sciences Corporation Information

6.6.2 Zyla Life Sciences Description and Business Overview

6.6.3 Zyla Life Sciences Meloxicam Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Zyla Life Sciences Meloxicam Product Portfolio

6.6.5 Zyla Life Sciences Recent Developments/Updates

6.7 Axsome Therapeutics

6.6.1 Axsome Therapeutics Corporation Information

6.6.2 Axsome Therapeutics Description and Business Overview

6.6.3 Axsome Therapeutics Meloxicam Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Axsome Therapeutics Meloxicam Product Portfolio

6.7.5 Axsome Therapeutics Recent Developments/Updates

6.8 Orbis Biosciences

6.8.1 Orbis Biosciences Corporation Information

6.8.2 Orbis Biosciences Description and Business Overview

6.8.3 Orbis Biosciences Meloxicam Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Orbis Biosciences Meloxicam Product Portfolio

6.8.5 Orbis Biosciences Recent Developments/Updates

6.9 Cellix Bio

6.9.1 Cellix Bio Corporation Information

6.9.2 Cellix Bio Description and Business Overview

6.9.3 Cellix Bio Meloxicam Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Cellix Bio Meloxicam Product Portfolio

6.9.5 Cellix Bio Recent Developments/Updates

6.10 Ligand Pharma

6.10.1 Ligand Pharma Corporation Information

6.10.2 Ligand Pharma Description and Business Overview

6.10.3 Ligand Pharma Meloxicam Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Ligand Pharma Meloxicam Product Portfolio

6.10.5 Ligand Pharma Recent Developments/Updates

6.11 SEDOR Pharma

6.11.1 SEDOR Pharma Corporation Information

6.11.2 SEDOR Pharma Meloxicam Description and Business Overview

6.11.3 SEDOR Pharma Meloxicam Sales, Revenue and Gross Margin (2019-2024)

6.11.4 SEDOR Pharma Meloxicam Product Portfolio

6.11.5 SEDOR Pharma Recent Developments/Updates

6.12 Heron Therapeutics

6.12.1 Heron Therapeutics Corporation Information

6.12.2 Heron Therapeutics Meloxicam Description and Business Overview

6.12.3 Heron Therapeutics Meloxicam Sales, Revenue and Gross Margin (2019-2024)

6.12.4 Heron Therapeutics Meloxicam Product Portfolio

6.12.5 Heron Therapeutics Recent Developments/Updates

6.13 Pacira BioSciences

6.13.1 Pacira BioSciences Corporation Information

6.13.2 Pacira BioSciences Meloxicam Description and Business Overview

6.13.3 Pacira BioSciences Meloxicam Sales, Revenue and Gross Margin (2019-2024)

6.13.4 Pacira BioSciences Meloxicam Product Portfolio

6.13.5 Pacira BioSciences Recent Developments/Updates

6.14 Sanofi

6.14.1 Sanofi Corporation Information

6.14.2 Sanofi Meloxicam Description and Business Overview

6.14.3 Sanofi Meloxicam Sales, Revenue and Gross Margin (2019-2024)

6.14.4 Sanofi Meloxicam Product Portfolio

6.14.5 Sanofi Recent Developments/Updates

6.15 Eurofarma Laboratorio

6.15.1 Eurofarma Laboratorio Corporation Information

6.15.2 Eurofarma Laboratorio Meloxicam Description and Business Overview

6.15.3 Eurofarma Laboratorio Meloxicam Sales, Revenue and Gross Margin (2019-2024)

6.15.4 Eurofarma Laboratorio Meloxicam Product Portfolio

6.15.5 Eurofarma Laboratorio Recent Developments/Updates

6.16 TerSera Therapeutics

6.16.1 TerSera Therapeutics Corporation Information

6.16.2 TerSera Therapeutics Meloxicam Description and Business Overview

6.16.3 TerSera Therapeutics Meloxicam Sales, Revenue and Gross Margin (2019-2024)

6.16.4 TerSera Therapeutics Meloxicam Product Portfolio

6.16.5 TerSera Therapeutics Recent Developments/Updates

6.17 Apotex

6.17.1 Apotex Corporation Information

6.17.2 Apotex Meloxicam Description and Business Overview

6.17.3 Apotex Meloxicam Sales, Revenue and Gross Margin (2019-2024)

6.17.4 Apotex Meloxicam Product Portfolio

6.17.5 Apotex Recent Developments/Updates

6.18 Yung Shin Pharmaceutical

6.18.1 Yung Shin Pharmaceutical Corporation Information

6.18.2 Yung Shin Pharmaceutical Meloxicam Description and Business Overview

6.18.3 Yung Shin Pharmaceutical Meloxicam Sales, Revenue and Gross Margin (2019-2024)

6.18.4 Yung Shin Pharmaceutical Meloxicam Product Portfolio

6.18.5 Yung Shin Pharmaceutical Recent Developments/Updates

6.19 Breckenridge Pharmaceutical

6.19.1 Breckenridge Pharmaceutical Corporation Information

6.19.2 Breckenridge Pharmaceutical Meloxicam Description and Business Overview

6.19.3 Breckenridge Pharmaceutical Meloxicam Sales, Revenue and Gross Margin (2019-2024)

6.19.4 Breckenridge Pharmaceutical Meloxicam Product Portfolio

6.19.5 Breckenridge Pharmaceutical Recent Developments/Updates

6.20 Zydus Pharmaceuticals

6.20.1 Zydus Pharmaceuticals Corporation Information

6.20.2 Zydus Pharmaceuticals Meloxicam Description and Business Overview

6.20.3 Zydus Pharmaceuticals Meloxicam Sales, Revenue and Gross Margin (2019-2024)

6.20.4 Zydus Pharmaceuticals Meloxicam Product Portfolio

6.20.5 Zydus Pharmaceuticals Recent Developments/Updates

6.21 Unichem Pharmaceuticals

6.21.1 Unichem Pharmaceuticals Corporation Information

6.21.2 Unichem Pharmaceuticals Meloxicam Description and Business Overview

6.21.3 Unichem Pharmaceuticals Meloxicam Sales, Revenue and Gross Margin (2019-2024)

6.21.4 Unichem Pharmaceuticals Meloxicam Product Portfolio

6.21.5 Unichem Pharmaceuticals Recent Developments/Updates

6.22 Strides Pharma

6.22.1 Strides Pharma Corporation Information

6.22.2 Strides Pharma Meloxicam Description and Business Overview

6.22.3 Strides Pharma Meloxicam Sales, Revenue and Gross Margin (2019-2024)

6.22.4 Strides Pharma Meloxicam Product Portfolio

6.22.5 Strides Pharma Recent Developments/Updates

6.23 Cipla

6.23.1 Cipla Corporation Information

6.23.2 Cipla Meloxicam Description and Business Overview

6.23.3 Cipla Meloxicam Sales, Revenue and Gross Margin (2019-2024)

6.23.4 Cipla Meloxicam Product Portfolio

6.23.5 Cipla Recent Developments/Updates

6.24 Dr. Reddy's Laboratories

6.24.1 Dr. Reddy's Laboratories Corporation Information

6.24.2 Dr. Reddy's Laboratories Meloxicam Description and Business Overview

6.24.3 Dr. Reddy's Laboratories Meloxicam Sales, Revenue and Gross Margin (2019-2024)

6.24.4 Dr. Reddy's Laboratories Meloxicam Product Portfolio

6.24.5 Dr. Reddy's Laboratories Recent Developments/Updates

6.25 Glenmark Pharmaceuticals

6.25.1 Glenmark Pharmaceuticals Corporation Information

6.25.2 Glenmark Pharmaceuticals Meloxicam Description and Business Overview

6.25.3 Glenmark Pharmaceuticals Meloxicam Sales, Revenue and Gross Margin (2019-2024)

6.25.4 Glenmark Pharmaceuticals Meloxicam Product Portfolio

6.25.5 Glenmark Pharmaceuticals Recent Developments/Updates

6.26 Teva

6.26.1 Teva Corporation Information

6.26.2 Teva Meloxicam Description and Business Overview

6.26.3 Teva Meloxicam Sales, Revenue and Gross Margin (2019-2024)

6.26.4 Teva Meloxicam Product Portfolio

6.26.5 Teva Recent Developments/Updates

6.27 PuraCap Pharmaceutical

6.27.1 PuraCap Pharmaceutical Corporation Information

6.27.2 PuraCap Pharmaceutical Meloxicam Description and Business Overview

6.27.3 PuraCap Pharmaceutical Meloxicam Sales, Revenue and Gross Margin (2019-2024)

6.27.4 PuraCap Pharmaceutical Meloxicam Product Portfolio

6.27.5 PuraCap Pharmaceutical Recent Developments/Updates

6.28 TARO

6.28.1 TARO Corporation Information

6.28.2 TARO Meloxicam Description and Business Overview

6.28.3 TARO Meloxicam Sales, Revenue and Gross Margin (2019-2024)

6.28.4 TARO Meloxicam Product Portfolio

6.28.5 TARO Recent Developments/Updates

6.29 Lupin Pharmaceuticals

6.29.1 Lupin Pharmaceuticals Corporation Information

6.29.2 Lupin Pharmaceuticals Meloxicam Description and Business Overview

6.29.3 Lupin Pharmaceuticals Meloxicam Sales, Revenue and Gross Margin (2019-2024)

6.29.4 Lupin Pharmaceuticals Meloxicam Product Portfolio

6.29.5 Lupin Pharmaceuticals Recent Developments/Updates

6.30 Aurobindo Pharma

6.30.1 Aurobindo Pharma Corporation Information

6.30.2 Aurobindo Pharma Meloxicam Description and Business Overview

6.30.3 Aurobindo Pharma Meloxicam Sales, Revenue and Gross Margin (2019-2024)

6.30.4 Aurobindo Pharma Meloxicam Product Portfolio

6.30.5 Aurobindo Pharma Recent Developments/Updates

6.31 Shanghai Bolinger Ingelheim Pharmaceutical

6.31.1 Shanghai Bolinger Ingelheim Pharmaceutical Corporation Information

6.31.2 Shanghai Bolinger Ingelheim Pharmaceutical Meloxicam Description and Business Overview

6.31.3 Shanghai Bolinger Ingelheim Pharmaceutical Meloxicam Sales, Revenue and Gross Margin (2019-2024)

6.31.4 Shanghai Bolinger Ingelheim Pharmaceutical Meloxicam Product Portfolio

6.31.5 Shanghai Bolinger Ingelheim Pharmaceutical Recent Developments/Updates

6.32 Shanghai Zhaohui Pharmaceutical

6.32.1 Shanghai Zhaohui Pharmaceutical Corporation Information

6.32.2 Shanghai Zhaohui Pharmaceutical Meloxicam Description and Business Overview

6.32.3 Shanghai Zhaohui Pharmaceutical Meloxicam Sales, Revenue and Gross Margin (2019-2024)

6.32.4 Shanghai Zhaohui Pharmaceutical Meloxicam Product Portfolio

6.32.5 Shanghai Zhaohui Pharmaceutical Recent Developments/Updates

6.33 Sichuan Shenghe Pharmaceutical

6.33.1 Sichuan Shenghe Pharmaceutical Corporation Information

6.33.2 Sichuan Shenghe Pharmaceutical Meloxicam Description and Business Overview

6.33.3 Sichuan Shenghe Pharmaceutical Meloxicam Sales, Revenue and Gross Margin (2019-2024)

6.33.4 Sichuan Shenghe Pharmaceutical Meloxicam Product Portfolio

6.33.5 Sichuan Shenghe Pharmaceutical Recent Developments/Updates

6.34 Ningxia Kangya Pharmaceutical

6.34.1 Ningxia Kangya Pharmaceutical Corporation Information

6.34.2 Ningxia Kangya Pharmaceutical Meloxicam Description and Business Overview

6.34.3 Ningxia Kangya Pharmaceutical Meloxicam Sales, Revenue and Gross Margin (2019-2024)

6.34.4 Ningxia Kangya Pharmaceutical Meloxicam Product Portfolio

6.34.5 Ningxia Kangya Pharmaceutical Recent Developments/Updates

6.35 Yangtze Pharmaceutical Group

6.35.1 Yangtze Pharmaceutical Group Corporation Information

6.35.2 Yangtze Pharmaceutical Group Meloxicam Description and Business Overview

6.35.3 Yangtze Pharmaceutical Group Meloxicam Sales, Revenue and Gross Margin (2019-2024)

6.35.4 Yangtze Pharmaceutical Group Meloxicam Product Portfolio

6.35.5 Yangtze Pharmaceutical Group Recent Developments/Updates

6.36 Kunshan Longdeng Ruidi Pharmaceutical

6.36.1 Kunshan Longdeng Ruidi Pharmaceutical Corporation Information

6.36.2 Kunshan Longdeng Ruidi Pharmaceutical Meloxicam Description and Business Overview

6.36.3 Kunshan Longdeng Ruidi Pharmaceutical Meloxicam Sales, Revenue and Gross Margin (2019-2024)

6.36.4 Kunshan Longdeng Ruidi Pharmaceutical Meloxicam Product Portfolio

6.36.5 Kunshan Longdeng Ruidi Pharmaceutical Recent Developments/Updates

6.37 Jiangsu Yabang Epson Pharmaceutical

6.37.1 Jiangsu Yabang Epson Pharmaceutical Corporation Information

6.37.2 Jiangsu Yabang Epson Pharmaceutical Meloxicam Description and Business Overview

6.37.3 Jiangsu Yabang Epson Pharmaceutical Meloxicam Sales, Revenue and Gross Margin (2019-2024)

6.37.4 Jiangsu Yabang Epson Pharmaceutical Meloxicam Product Portfolio

6.37.5 Jiangsu Yabang Epson Pharmaceutical Recent Developments/Updates

6.38 Jiangsu Feima Pharmaceutical Co. , Ltd

6.38.1 Jiangsu Feima Pharmaceutical Co. , Ltd Corporation Information

6.38.2 Jiangsu Feima Pharmaceutical Co. , Ltd Meloxicam Description and Business Overview

6.38.3 Jiangsu Feima Pharmaceutical Co. , Ltd Meloxicam Sales, Revenue and Gross Margin (2019-2024)

6.38.4 Jiangsu Feima Pharmaceutical Co. , Ltd Meloxicam Product Portfolio

6.38.5 Jiangsu Feima Pharmaceutical Co. , Ltd Recent Developments/Updates

6.39 Zhejiang Xianju Pharmaceutical

6.39.1 Zhejiang Xianju Pharmaceutical Corporation Information

6.39.2 Zhejiang Xianju Pharmaceutical Meloxicam Description and Business Overview

6.39.3 Zhejiang Xianju Pharmaceutical Meloxicam Sales, Revenue and Gross Margin (2019-2024)

6.39.4 Zhejiang Xianju Pharmaceutical Meloxicam Product Portfolio

6.39.5 Zhejiang Xianju Pharmaceutical Recent Developments/Updates

6.40 Hainan All Star Pharmaceutical

6.40.1 Hainan All Star Pharmaceutical Corporation Information

6.40.2 Hainan All Star Pharmaceutical Meloxicam Description and Business Overview

6.40.3 Hainan All Star Pharmaceutical Meloxicam Sales, Revenue and Gross Margin (2019-2024)

6.40.4 Hainan All Star Pharmaceutical Meloxicam Product Portfolio

6.40.5 Hainan All Star Pharmaceutical Recent Developments/Updates

6.41 Hainan Aomeihua Pharmaceutical

6.42 Hunan Mingrui Pharmaceutical

6.43 Suzhou Sinochem Pharmaceutical

6.44 Qilu Pharmaceutical

6.45 Sichuan Luye Pharmaceutical

6.46 Shandong Xinhua Pharmaceutical

6.47 Guangdong Renkang Pharmaceutical

6.48 Hainan Selike Pharmaceutical

7 Industry Chain and Sales Channels Analysis

7.1 Meloxicam Industry Chain Analysis

7.2 Meloxicam Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Meloxicam Production Mode & Process

7.4 Meloxicam Sales and Marketing

7.4.1 Meloxicam Sales Channels

7.4.2 Meloxicam Distributors

7.5 Meloxicam Customers

8 Meloxicam Market Dynamics

8.1 Meloxicam Industry Trends

8.2 Meloxicam Market Drivers

8.3 Meloxicam Market Challenges

8.4 Meloxicam Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Eurofarma Laboratorio

TerSera Therapeutics

Apotex

Yung Shin Pharmaceutical

Breckenridge Pharmaceutical

Zydus Pharmaceuticals

Unichem Pharmaceuticals

Strides Pharma

Cipla Ltd

Dr. Reddy’s Laboratories

Glenmark Pharmaceuticals

TEVA

PuraCap Pharmaceutical

Taro

Lupin Pharmaceuticals

Aurobindo Pharma

Shanghai Bolinger Ingelheim Pharmaceutical

Shanghai Zhaohui Pharmaceutical

Sichuan Shenghe Pharmaceutical

Ningxia Kangya Pharmaceutical

Yangtze Pharmaceutical Group

Kunshan Longdeng Ruidi Pharmaceutical

Jiangsu Yabang Epson Pharmaceutical

Jiangsu Feima Pharmaceutical Co. , Ltd

Zhejiang Xianju Pharmaceutical

Hainan All Star Pharmaceutical

Hainan Aomeihua Pharmaceutical

Hunan Mingrui Pharmaceutical

Suzhou Sinochem Pharmaceutical

Qilu Pharmaceutical

Sichuan Luye Pharmaceutical

Shandong Xinhua Pharmaceutical

Guangdong Renkang Pharmaceutical

Hainan Selike Pharmaceutical

List of Tables

Table 1. Global Meloxicam Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Meloxicam Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Meloxicam Market Competitive Situation by Manufacturers in 2023

Table 4. Global Meloxicam Sales (KG) of Key Manufacturers (2019-2024)

Table 5. Global Meloxicam Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Meloxicam Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Meloxicam Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Meloxicam Average Price (US$/G) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Meloxicam, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Meloxicam, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Meloxicam, Product Type & Application

Table 12. Global Key Manufacturers of Meloxicam, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Meloxicam by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meloxicam as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Meloxicam Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Meloxicam Sales by Region (2019-2024) & (KG)

Table 18. Global Meloxicam Sales Market Share by Region (2019-2024)

Table 19. Global Meloxicam Sales by Region (2025-2030) & (KG)

Table 20. Global Meloxicam Sales Market Share by Region (2025-2030)

Table 21. Global Meloxicam Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Meloxicam Revenue Market Share by Region (2019-2024)

Table 23. Global Meloxicam Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Meloxicam Revenue Market Share by Region (2025-2030)

Table 25. North America Meloxicam Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Meloxicam Sales by Country (2019-2024) & (KG)

Table 27. North America Meloxicam Sales by Country (2025-2030) & (KG)

Table 28. North America Meloxicam Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Meloxicam Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Meloxicam Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Meloxicam Sales by Country (2019-2024) & (KG)

Table 32. Europe Meloxicam Sales by Country (2025-2030) & (KG)

Table 33. Europe Meloxicam Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Meloxicam Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Meloxicam Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Meloxicam Sales by Region (2019-2024) & (KG)

Table 37. Asia Pacific Meloxicam Sales by Region (2025-2030) & (KG)

Table 38. Asia Pacific Meloxicam Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Meloxicam Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Meloxicam Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Meloxicam Sales by Country (2019-2024) & (KG)

Table 42. Latin America Meloxicam Sales by Country (2025-2030) & (KG)

Table 43. Latin America Meloxicam Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Meloxicam Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Meloxicam Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Meloxicam Sales by Country (2019-2024) & (KG)

Table 47. Middle East & Africa Meloxicam Sales by Country (2025-2030) & (KG)

Table 48. Middle East & Africa Meloxicam Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Meloxicam Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Meloxicam Sales (KG) by Type (2019-2024)

Table 51. Global Meloxicam Sales (KG) by Type (2025-2030)

Table 52. Global Meloxicam Sales Market Share by Type (2019-2024)

Table 53. Global Meloxicam Sales Market Share by Type (2025-2030)

Table 54. Global Meloxicam Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Meloxicam Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Meloxicam Revenue Market Share by Type (2019-2024)

Table 57. Global Meloxicam Revenue Market Share by Type (2025-2030)

Table 58. Global Meloxicam Price (US$/G) by Type (2019-2024)

Table 59. Global Meloxicam Price (US$/G) by Type (2025-2030)

Table 60. Global Meloxicam Sales (KG) by Application (2019-2024)

Table 61. Global Meloxicam Sales (KG) by Application (2025-2030)

Table 62. Global Meloxicam Sales Market Share by Application (2019-2024)

Table 63. Global Meloxicam Sales Market Share by Application (2025-2030)

Table 64. Global Meloxicam Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Meloxicam Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Meloxicam Revenue Market Share by Application (2019-2024)

Table 67. Global Meloxicam Revenue Market Share by Application (2025-2030)

Table 68. Global Meloxicam Price (US$/G) by Application (2019-2024)

Table 69. Global Meloxicam Price (US$/G) by Application (2025-2030)

Table 70. Boehringer Ingelheim Corporation Information

Table 71. Boehringer Ingelheim Description and Business Overview

Table 72. Boehringer Ingelheim Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)

Table 73. Boehringer Ingelheim Meloxicam Product

Table 74. Boehringer Ingelheim Recent Developments/Updates

Table 75. Baudax Corporation Information

Table 76. Baudax Description and Business Overview

Table 77. Baudax Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)

Table 78. Baudax Meloxicam Product

Table 79. Baudax Recent Developments/Updates

Table 80. Perrigo Corporation Information

Table 81. Perrigo Description and Business Overview

Table 82. Perrigo Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)

Table 83. Perrigo Meloxicam Product

Table 84. Perrigo Recent Developments/Updates

Table 85. Recro Pharma Corporation Information

Table 86. Recro Pharma Description and Business Overview

Table 87. Recro Pharma Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)

Table 88. Recro Pharma Meloxicam Product

Table 89. Recro Pharma Recent Developments/Updates

Table 90. Iroko Pharma Corporation Information

Table 91. Iroko Pharma Description and Business Overview

Table 92. Iroko Pharma Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)

Table 93. Iroko Pharma Meloxicam Product

Table 94. Iroko Pharma Recent Developments/Updates

Table 95. Zyla Life Sciences Corporation Information

Table 96. Zyla Life Sciences Description and Business Overview

Table 97. Zyla Life Sciences Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)

Table 98. Zyla Life Sciences Meloxicam Product

Table 99. Zyla Life Sciences Recent Developments/Updates

Table 100. Axsome Therapeutics Corporation Information

Table 101. Axsome Therapeutics Description and Business Overview

Table 102. Axsome Therapeutics Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)

Table 103. Axsome Therapeutics Meloxicam Product

Table 104. Axsome Therapeutics Recent Developments/Updates

Table 105. Orbis Biosciences Corporation Information

Table 106. Orbis Biosciences Description and Business Overview

Table 107. Orbis Biosciences Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)

Table 108. Orbis Biosciences Meloxicam Product

Table 109. Orbis Biosciences Recent Developments/Updates

Table 110. Cellix Bio Corporation Information

Table 111. Cellix Bio Description and Business Overview

Table 112. Cellix Bio Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)

Table 113. Cellix Bio Meloxicam Product

Table 114. Cellix Bio Recent Developments/Updates

Table 115. Ligand Pharma Corporation Information

Table 116. Ligand Pharma Description and Business Overview

Table 117. Ligand Pharma Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)

Table 118. Ligand Pharma Meloxicam Product

Table 119. Ligand Pharma Recent Developments/Updates

Table 120. SEDOR Pharma Corporation Information

Table 121. SEDOR Pharma Description and Business Overview

Table 122. SEDOR Pharma Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)

Table 123. SEDOR Pharma Meloxicam Product

Table 124. SEDOR Pharma Recent Developments/Updates

Table 125. Heron Therapeutics Corporation Information

Table 126. Heron Therapeutics Description and Business Overview

Table 127. Heron Therapeutics Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)

Table 128. Heron Therapeutics Meloxicam Product

Table 129. Heron Therapeutics Recent Developments/Updates

Table 130. Pacira BioSciences Corporation Information

Table 131. Pacira BioSciences Description and Business Overview

Table 132. Pacira BioSciences Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)

Table 133. Pacira BioSciences Meloxicam Product

Table 134. Pacira BioSciences Recent Developments/Updates

Table 135. Sanofi Corporation Information

Table 136. Sanofi Description and Business Overview

Table 137. Sanofi Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)

Table 138. Sanofi Meloxicam Product

Table 139. Sanofi Recent Developments/Updates

Table 140. Eurofarma Laboratorio Corporation Information

Table 141. Eurofarma Laboratorio Description and Business Overview

Table 142. Eurofarma Laboratorio Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)

Table 143. Eurofarma Laboratorio Meloxicam Product

Table 144. Eurofarma Laboratorio Recent Developments/Updates

Table 145. TerSera Therapeutics Corporation Information

Table 146. TerSera Therapeutics Description and Business Overview

Table 147. TerSera Therapeutics Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)

Table 148. TerSera Therapeutics Meloxicam Product

Table 149. TerSera Therapeutics Recent Developments/Updates

Table 150. Apotex Corporation Information

Table 151. Apotex Description and Business Overview

Table 152. Apotex Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)

Table 153. Apotex Meloxicam Product

Table 154. Apotex Recent Developments/Updates

Table 155. Yung Shin Pharmaceutical Corporation Information

Table 156. Yung Shin Pharmaceutical Description and Business Overview

Table 157. Yung Shin Pharmaceutical Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)

Table 158. Yung Shin Pharmaceutical Meloxicam Product

Table 159. Yung Shin Pharmaceutical Recent Developments/Updates

Table 160. Breckenridge Pharmaceutical Corporation Information

Table 161. Breckenridge Pharmaceutical Description and Business Overview

Table 162. Breckenridge Pharmaceutical Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)

Table 163. Breckenridge Pharmaceutical Meloxicam Product

Table 164. Breckenridge Pharmaceutical Recent Developments/Updates

Table 165. Zydus Pharmaceuticals Corporation Information

Table 166. Zydus Pharmaceuticals Description and Business Overview

Table 167. Zydus Pharmaceuticals Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)

Table 168. Zydus Pharmaceuticals Meloxicam Product

Table 169. Zydus Pharmaceuticals Recent Developments/Updates

Table 170. Unichem Pharmaceuticals Corporation Information

Table 171. Unichem Pharmaceuticals Description and Business Overview

Table 172. Unichem Pharmaceuticals Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)

Table 173. Unichem Pharmaceuticals Meloxicam Product

Table 174. Unichem Pharmaceuticals Recent Developments/Updates

Table 175. Strides Pharma Corporation Information

Table 176. Strides Pharma Description and Business Overview

Table 177. Strides Pharma Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)

Table 178. Strides Pharma Meloxicam Product

Table 179. Strides Pharma Recent Developments/Updates

Table 180. Cipla Corporation Information

Table 181. Cipla Description and Business Overview

Table 182. Cipla Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)

Table 183. Cipla Meloxicam Product

Table 184. Cipla Recent Developments/Updates

Table 185. Dr. Reddy's Laboratories Corporation Information

Table 186. Dr. Reddy's Laboratories Description and Business Overview

Table 187. Dr. Reddy's Laboratories Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)

Table 188. Dr. Reddy's Laboratories Meloxicam Product

Table 189. Dr. Reddy's Laboratories Recent Developments/Updates

Table 190. Glenmark Pharmaceuticals Corporation Information

Table 191. Glenmark Pharmaceuticals Description and Business Overview

Table 192. Glenmark Pharmaceuticals Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)

Table 193. Glenmark Pharmaceuticals Meloxicam Product

Table 194. Glenmark Pharmaceuticals Recent Developments/Updates

Table 195. Teva Corporation Information

Table 196. Teva Description and Business Overview

Table 197. Teva Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)

Table 198. Teva Meloxicam Product

Table 199. Teva Recent Developments/Updates

Table 200. PuraCap Pharmaceutical Corporation Information

Table 201. PuraCap Pharmaceutical Description and Business Overview

Table 202. PuraCap Pharmaceutical Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)

Table 203. PuraCap Pharmaceutical Meloxicam Product

Table 204. PuraCap Pharmaceutical Recent Developments/Updates

Table 205. TARO Corporation Information

Table 206. TARO Description and Business Overview

Table 207. TARO Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)

Table 208. TARO Meloxicam Product

Table 209. TARO Recent Developments/Updates

Table 210. Lupin Pharmaceuticals Corporation Information

Table 211. Lupin Pharmaceuticals Description and Business Overview

Table 212. Lupin Pharmaceuticals Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)

Table 213. Lupin Pharmaceuticals Meloxicam Product

Table 214. Lupin Pharmaceuticals Recent Developments/Updates

Table 215. Aurobindo Pharma Corporation Information

Table 216. Aurobindo Pharma Description and Business Overview

Table 217. Aurobindo Pharma Meloxicam Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)

Table 218. Aurobindo Pharma Meloxicam Product

Table 219. Aurobindo Pharma Recent Developments/Updates

Table 220. Key Raw Materials Lists

Table 221. Raw Materials Key Suppliers Lists

Table 222. Meloxicam Distributors List

Table 223. Meloxicam Customers List

Table 224. Meloxicam Market Trends

Table 225. Meloxicam Market Drivers

Table 226. Meloxicam Market Challenges

Table 227. Meloxicam Market Restraints

Table 228. Research Programs/Design for This Report

Table 229. Key Data Information from Secondary Sources

Table 230. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Meloxicam

Figure 2. Global Meloxicam Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Meloxicam Market Share by Type in 2023 & 2030

Figure 4. Combination Drugs Product Picture

Figure 5. Prescribed Drugs Product Picture

Figure 6. Global Meloxicam Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Meloxicam Market Share by Application in 2023 & 2030

Figure 8. Rheumatoid Arthritis

Figure 9. Osteoarthritis

Figure 10. Soft Tissue Inflammation

Figure 11. Traumatic Pain

Figure 12. Post-Operative Pain

Figure 13. Other

Figure 14. Global Meloxicam Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Meloxicam Market Size (2019-2030) & (US$ Million)

Figure 16. Global Meloxicam Sales (2019-2030) & (KG)

Figure 17. Global Meloxicam Average Price (US$/G) & (2019-2030)

Figure 18. Meloxicam Report Years Considered

Figure 19. Meloxicam Sales Share by Manufacturers in 2023

Figure 20. Global Meloxicam Revenue Share by Manufacturers in 2023

Figure 21. The Global 5 and 10 Largest Meloxicam Players: Market Share by Revenue in 2023

Figure 22. Meloxicam Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 23. Global Meloxicam Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 24. North America Meloxicam Sales Market Share by Country (2019-2030)

Figure 25. North America Meloxicam Revenue Market Share by Country (2019-2030)

Figure 26. U.S. Meloxicam Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. Canada Meloxicam Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. Europe Meloxicam Sales Market Share by Country (2019-2030)

Figure 29. Europe Meloxicam Revenue Market Share by Country (2019-2030)

Figure 30. Germany Meloxicam Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. France Meloxicam Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. U.K. Meloxicam Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Italy Meloxicam Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Russia Meloxicam Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Asia Pacific Meloxicam Sales Market Share by Region (2019-2030)

Figure 36. Asia Pacific Meloxicam Revenue Market Share by Region (2019-2030)

Figure 37. China Meloxicam Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Japan Meloxicam Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. South Korea Meloxicam Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. India Meloxicam Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Australia Meloxicam Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Taiwan Meloxicam Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Indonesia Meloxicam Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Thailand Meloxicam Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Malaysia Meloxicam Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Philippines Meloxicam Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Latin America Meloxicam Sales Market Share by Country (2019-2030)

Figure 48. Latin America Meloxicam Revenue Market Share by Country (2019-2030)

Figure 49. Mexico Meloxicam Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Brazil Meloxicam Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Argentina Meloxicam Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Middle East & Africa Meloxicam Sales Market Share by Country (2019-2030)

Figure 53. Middle East & Africa Meloxicam Revenue Market Share by Country (2019-2030)

Figure 54. Turkey Meloxicam Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 55. Saudi Arabia Meloxicam Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 56. UAE Meloxicam Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 57. Global Sales Market Share of Meloxicam by Type (2019-2030)

Figure 58. Global Revenue Market Share of Meloxicam by Type (2019-2030)

Figure 59. Global Meloxicam Price (US$/G) by Type (2019-2030)

Figure 60. Global Sales Market Share of Meloxicam by Application (2019-2030)

Figure 61. Global Revenue Market Share of Meloxicam by Application (2019-2030)

Figure 62. Global Meloxicam Price (US$/G) by Application (2019-2030)

Figure 63. Meloxicam Value Chain

Figure 64. Meloxicam Production Process

Figure 65. Channels of Distribution (Direct Vs Distribution)

Figure 66. Distributors Profiles

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions